In contrast, patients with untreated newly diagnosed multiple myeloma had a similar CD4/CD8 ratio to HDs suggesting that prior antimyeloma treatment may have an impact on the CD4/CD8 ratio. The gene discussed is CD8A; the disease is plasma cell myeloma.